Sign In
Buy MCRB
$4.83
+0.0500 (+1.05%)
At Close: Jul 31, 2026
Seres Therapeutics (MCRB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
10:34am, Thursday, 25'th Jul 2019
Seres Therapeutics (MCRB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Largest insider trades of the week: June 21
12:45pm, Friday, 21'st Jun 2019
The GuruFocus All-in-One Screener can be used to find insider trades from the past week.
Seres Therapeutics (MCRB) CEO Eric Shaff on Q1 2019 Results - Earnings Call Transcript
02:00am, Monday, 06'th May 2019
Seres Therapeutics (MCRB) CEO Eric Shaff on Q1 2019 Results - Earnings Call Transcript
5 New Stocks Trading Under $10 With Monumental Implied Upside
07:10am, Saturday, 04'th May 2019
Most firms on Wall Street focus on large and mega cap stocks, as they provide a degree of safety and liquidity.
Seres Therapeutics (MCRB) Reports Q1 Loss, Lags Revenue Estimates
09:25am, Thursday, 02'nd May 2019
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -27.91% and -15.00%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Seres Therapeutics Stock Soared Today
01:55pm, Monday, 11'th Mar 2019
A new collaboration with AstraZeneca could give microbiome-based medicine a big lift.
5 Stocks Trading Under $10 That Could Have Gigantic Upside Potential
09:32pm, Friday, 08'th Mar 2019
While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
